Skip to main content
PMC home page
British Medical Journal logoLink to British Medical Journal
. 1958 Apr 26;1(5077):963–966. doi: 10.1136/bmj.1.5077.963

Chlorothiazide in Control of Ascites in Hepatic Cirrhosis

A E Read, R M Haslam, J Laidlaw, Sheila Sherlock
PMCID: PMC2028384  PMID: 13536388

Full text

PDF
963

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ATKINSON M., PATON A., SHERLOCK S. Control of ascites in hepatic cirrhosis. Lancet. 1954 Jan 16;266(6803):128–129. doi: 10.1016/s0140-6736(54)90980-0. [DOI] [PubMed] [Google Scholar]
  2. BAYLISS R. I., MARRACK D., PIRKIS J., REES J. R., ZILVA J. F. Chlorothiazide: an oral diuretic. Lancet. 1958 Jan 18;1(7012):120–124. doi: 10.1016/s0140-6736(58)90610-x. [DOI] [PubMed] [Google Scholar]
  3. DAWSON A. M., DE GROOTE J., ROSENTHAL W. A., SHERLOCK S. The effects of diamox ammonia metabolism in liver disease. Clin Sci. 1957 Aug;16(3):413–420. [PubMed] [Google Scholar]
  4. EISENMENGER W. J. Rôle of sodium in the formation and control of ascites in patients with cirrhosis. Ann Intern Med. 1952 Aug;37(2):261–272. doi: 10.7326/0003-4819-37-2-261. [DOI] [PubMed] [Google Scholar]
  5. FOLEY J. M., WATSON C. W., ADAMS R. D. Significance of the electroencephalographic changes in hepatic coma. Trans Am Neurol Assoc. 1950;51:161–165. [PubMed] [Google Scholar]
  6. HECKER R., SHERLOCK S. Electrolyte and circulatory changes in terminal liver failure. Lancet. 1956 Dec 1;271(6953):1121–1125. doi: 10.1016/s0140-6736(56)90149-0. [DOI] [PubMed] [Google Scholar]
  7. LARAGH J. H., HEINEMANN H. O., DEMARTINI F. E. Effect of chlorothiazide on electrolyte transport in man; its use in the treatment of edema of congestive heart failure, nephrosis, and cirrhosis. J Am Med Assoc. 1958 Jan 11;166(2):145–152. doi: 10.1001/jama.1958.02990020033006. [DOI] [PubMed] [Google Scholar]
  8. MOYER J. H., FORD R. V., SPURR C. L. [Pharmacodynamics of chlorothiazide (Diuril), an orally effective non-mercurial diuretic agent]. Proc Soc Exp Biol Med. 1957 Jul;95(3):529–531. doi: 10.3181/00379727-95-23277. [DOI] [PubMed] [Google Scholar]
  9. PARSONS-SMITH B. G., SUMMERSKILL W. H., DAWSON A. M., SHERLOCK S. The electroencephalograph in liver disease. Lancet. 1957 Nov 2;273(7001):867–871. doi: 10.1016/s0140-6736(57)90005-3. [DOI] [PubMed] [Google Scholar]
  10. SCHREINER G. E., BLOOMER H. A. Effect of chlorothiazide on the edema of cirrhosis, nephrosis, congestive heart failure and chronic renal insufficiency. N Engl J Med. 1957 Nov 21;257(21):1016–1022. doi: 10.1056/NEJM195711212572103. [DOI] [PubMed] [Google Scholar]
  11. SLATER J. D., NABARRO J. D. Clinical experience with chlorothiazide. Lancet. 1958 Jan 18;1(7012):124–127. doi: 10.1016/s0140-6736(58)90611-1. [DOI] [PubMed] [Google Scholar]
  12. WEBSTER L. T., Jr, DAVIDSON C. S. Production of impending hepatic coma by a carbonic anhydrase inhibitor, diamox. Proc Soc Exp Biol Med. 1956 Jan;91(1):27–31. doi: 10.3181/00379727-91-22159. [DOI] [PubMed] [Google Scholar]
  13. WOLFF H. P., KOCZOREK K. R., JESCH W., BUCHBORN E. Untersuchungen über die Aldosteronausscheidung bei Leberkranken. Klin Wochenschr. 1956 Apr 1;34(13-14):366–371. doi: 10.1007/BF01469350. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES